Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Gains from Investment Securities (2016 - 2025)

Natural Health Trends' Gains from Investment Securities history spans 15 years, with the latest figure at -$976000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 670.76% year-over-year to -$976000.0; the TTM value through Dec 2025 reached -$1.0 million, down 526.36%, while the annual FY2025 figure was $1.1 million, 0.0% changed from the prior year.
  • Gains from Investment Securities reached -$976000.0 in Q4 2025 per NHTC's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q3 2024 to a low of -$976000.0 in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $257956.6, with a median of $97900.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: surged 56184.15% in 2022, then plummeted 670.76% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$584000.0 in 2021, then skyrocketed by 103.94% to $23000.0 in 2022, then skyrocketed by 325.65% to $97900.0 in 2023, then skyrocketed by 74.67% to $171000.0 in 2024, then tumbled by 670.76% to -$976000.0 in 2025.
  • Per Business Quant, the three most recent readings for NHTC's Gains from Investment Securities are -$976000.0 (Q4 2025), $1.1 million (Q3 2025), and -$101000.0 (Q2 2025).